A. Yu. Kovalenko

A. Yu. Kovalenko

Auto-generated profile, based on publicly available information

A. Yu. Kovalenko

Russian Research Institute of Hematology and Transfusiology of Federal Medical and Biological Agency

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Russian Journal of Geriatric Medicine
Verified
Journal Article
Open access
PDF file
EKElena Vladimirovna Korotkova
Elena Vladimirovna Korotkova
AZA. V. Zavyalov
A. V. Zavyalov
AKA. Yu. Kovalenko
A. Yu. Kovalenko
Lipoprotein (а) is able to initiate mechanisms of inflammation and create an atherogenic and thrombophilic condition due to its structural features. It is important to acknowledge that there are currently no standardized protocols for the regular monitoring of lipoprotein (а) levels in clinical settings, despite its relevance in assessing cardiovascular risk among older patients. Even in the absence of abnormal lipid profiles, there may still be thickening of the arterial walls and the formation of atherosclerotic plaque. The extent of atherogenicity, or plaque development, is directly linked to plasma levels of lipoprotein (а), which have a genetic basis.This paper aims to review the role of lipoprotein (а) in low-grade inflammation and its pathogenic mechanisms in atherosclerosis, particularly in relation to elevated levels of this lipoprotein. The study will critically analyze the available literature on this topic to understand the potential role of lipoprotein (а) as a risk factor for atherosclerosis.

16 May 2026 in Russian Journal for Personalized Medicine
Verified
Journal Article
Closed access
ASA. Yu. Shchapova
A. Yu. Shchapova
OMO. Yu. Matvienko
O. Yu. Matvienko
IKI. I. Krobinets
I. I. Krobinets
SGS. V. Gavrovskaya
S. V. Gavrovskaya
NSN. N. Silina
N. N. Silina
Background. The vascular endothelium serves as a key organ in regulating hemostasis, vasodilation, and anticoagulant balance. Endothelial dysfunction (ED) plays a central role in the pathogenesis of atherosclerosis, thrombosis, inflammatory diseases, and COVID-19 complications, manifesting as reduced NO-dependent vasodilation, activation of coagulation, and loss of the antithrombogenic properties of the vascular intima. Assessment of endothelial function holds significant clinical potential for diagnosis, prognosis, and therapy monitoring; however, existing methods are limited in terms of specificity, reproducibility, and interpretation. Objective. To systematize current data on the advantages and disadvantages of methods for assessing endothelial function, including biomarkers, functional tests, and coagulological approaches. Materials and methods. A systematic literature search was performed in PubMed, PMC, ResearchGate, Scopus, and Web of Science databases for the period from 2000 to 2026. Keywords included “endothelial dysfunction assessment”, “hemostasis biomarkers”, and others. Reviews, meta-analyses, and original studies in English and Russian were included; abstracts and case reports without statistical data were excluded. Results. Biomarkers (vWF, sPECAM-1, sP-selectin, VEGF, PGI2, endocan, syndecans) reflect endothelial activation and damage but lack specificity in the context of inflammation. Functional tests (FMD, viscometry) evaluate vasoreactivity and rheology but require rigorous standardization. Coagulological methods (platelet aggregation, protein C activity) provide indirect indicators of dysfunction. Promising approaches include flow cytometry (CECs, EVs) and microfluidic chambers for cellular analysis. Conclusion. A combination of methods is preferable for comprehensive assessment; future prospects lie in standardized protocols for predicting thrombotic risks and guiding therapy.

9 October 2026 in Extreme Medicine
Verified
Journal Article
Open access
PDF file
IKI. I. Krobinets
I. I. Krobinets
NBN. N. Bodrova
N. N. Bodrova
ASA. Yu. Shchapova
A. Yu. Shchapova
OMO. Yu. Matvienko
O. Yu. Matvienko
OSO. A. Smirnova
O. A. Smirnova
ОЭО. В. Эйхлер
О. В. Эйхлер
Immunoadsorption-based plasma preparation: In vitro evaluation of anti-A and anti-B antibody depletion and Factor VIII activity preservation | Krobinets | Extreme Medicine Разработка технологии получения плазмы методом иммуносорбции: in vitro оценка эффективности удаления анти-A/анти-B антител и сохранности активности фактора VIII | Кробинец | Экстремальная биомедицина

12 July 2025 in Marine Medicine
Verified
Journal Article
Open access
PDF file
AGA. V. Golubeva
A. V. Golubeva
AKA. Yu. Kovalenko
A. Yu. Kovalenko
AGA. G. Grigoryan
A. G. Grigoryan
INTRODUCTION. Assessment of the quality of medical care is the most important element of modern healthcare aimed at improving the effectiveness of treatment, patient satisfaction and ensuring the safety of medical services. The development of innovative technologies, the need to standardize approaches to diagnosis and therapy require improvement of existing methods of assessment. OBJECTIVE. Analyze existing methods for assessing the quality of medical care, identify their limitations and factors affecting the accuracy and objectivity of the assessment, and develop recommendations for their improvement. MATERIALS AND METHODS. The study is based on the analysis of scientific publications presented in international databases (PubMed, Scopus, Web of Science) and the Russian scientific electronic resource eLIBRARY.RU. Key words used: assessment of the quality of medical care, patient satisfaction, quality of life assessment scales. The works published in the period from 2010 to 2024 were included. The methods of content analysis, comparative analysis and statistical data processing were used. RESULTS. The analysis showed that the most common model for assessing the quality of medical care is the Donnabedien model, which includes three key components: structure, process and outcome. An important role is played by standardized quality of life assessment scales (SF-36, EQ-5D, WHOQOL-BREF), which provide a comprehensive indicator of the impact of medical interventions on patients. It is shown that the key indicators are patient satisfaction, clinical outcomes, accessibility and safety of medical services. DISCUSSION. Current trends in assessing the quality of care include an increased emphasis on the integration of digital technologies, big data analysis, the use of electronic medical records and clinical decision support systems. There are revealed problems related to the subjectivity of conclusions, the need for cultural adaptation of quality of life assessment scales and the variability of applied methodologies in different countries. CONCLUSION. Improvement of the system for assessing the quality of medical care requires a comprehensive approach, including standardization of methods, adaptation of quality of life assessment scales, integration of digital technologies and increased attention to patient safety. The study results can be used to optimize the quality management of medical services and develop effective strategies to improve patient satisfaction.